Skip to contentB
Bio-Rad Laboratories, Inc.
B
BIOBio-Rad Laboratories, Inc. Q1 2019 · 10-Q
Revenue$553.98M$553.98M+0.4% vs Q1 2018 Net Income$865.20M$865.20M+31.7% vs Q1 2018 EPS Diluted$28.74$28.74+32.0% vs Q1 2018 Gross Profit$311,800,000+3.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Rad Laboratories, Inc. · CIK 12208 · Engraved from SEC EDGAR
Operating Cash Flow$42,943,000+6.4% Free Cash Flowderived$19,314,000+46.7% Margins · derivedGross margin56.3%+1.5 pt vs Q1 2018
Operating margin10.2%+2.3 pt vs Q1 2018
Net margin156.2%+37.1 pt vs Q1 2018
ended Mar 31, 2019 · filed May 10, 2019 · 40 d after period end